Viatris Sells Biosimilars Portfolio to Biocon Biologics for up to $3.335 Bilion

(PLX AI) – Viatris Combination of its Biosimilars Portfolio with Biocon Biologics in Exchange for up to $3.335 Billion.Viatris will receive $3 billion in consideration in the form of a $2 billion cash payment and $1 billion of convertible preferred …